Dicycloplatin | m-entrepreneurship.com

Product Name :
Dicycloplatin

Search keywords :
Dicycloplatin

drugId :
null

Target Vo:
DNA

Target Vo Short Name :
DNA

Moa_Name:
Alkylating agents

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Beijing Suopingda Pharmaceutical Research Co Ltd

Active Company_Name :
Beijing Suopingda Pharmaceutical Research Co Ltd

Active Indication_Name:
Prostatic Neoplasms, Castration-Resistant

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-AMPK alpha 2 (Thr172) Antibody
DRP1 Antibody
PDIA6 Antibody: PDIA6 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to PDIA6. It can be used for WB,ICC/IF,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts